Upsher-Smith Launches Olanzapine Tablets, USP

Maple Grove, MN – October 17, 2024 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of Olanzapine Tablets, USP, in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg strengths. The Olanzapine Tablet market had U.S. sales of approximately $46 million for the 12 months ending August 2024, according to IQVIA. The Therapeutic Equivalence (TE) code for the product is AB, and the original Reference Listed Drug (RLD) was the brand Zyprexa^®*.